Alto Capital's Tony Locantro discusses recent updates from Exopharm Ltd (ASX:EX1) including preclinical data from its osteoarthritis animal study as well as positive safety results from its PLEXOVAL II Phase 1 study. He also talks through assay results from Godolphin Resources Limited's (ASX:GRL) first diamond drill hole at Lewis Ponds as well as the wait for assays from Aurumin Limited (ASX:AUN) following completion of its RC drilling programme at Mt Dimer.
Tony Locantro sees 'massive future' for Exopharm Ltd
